There’s a slowdown in agro segment but better traction in pharma, monomers & personal care: Anupam Rasayan management
Thakkar and Agrawal foresee revenue growth in FY25, stable margins, and positive long-term outlook. Anupam Rasayan's strategic investments, pass-through pricing, and market performance drive the company's growth trajectory. Thakkar says: " Japan is one geography that has really worked well for us and we are seeing a lot of buoyancy there. "
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
